MedTrace Logo

Survey on the Effect of Health Related Quality of Life (QOL) Associated With Compliance of Carbocisteine in Asthma Patients

NCT01693471 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 179

Last updated 2013-03-01

No results posted yet for this study

Summary

The objectives of this study are to investigate the influence on HR-QOL (SF-36 v2) resulting from the compliance of MUCODYNE Tablets or MUCODYNE DS (Dry Syrup) 50% in asthma patients whose control levels are partly controlled or uncontrolled.

Conditions

Sponsors & Collaborators

  • Kyorin Pharmaceutical Co.,Ltd

    lead INDUSTRY

Principal Investigators

  • Akito Saegusa, Mr. · Kyorin Pharmaceutical Co.,Ltd

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2012-12-31
Completion
2013-01-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01693471 on ClinicalTrials.gov